Drug Companies: A Powerhouse of Profits
by The Investment U Research Team
A couple of interesting news items came out in the past few days. One, a research report showing how expensive treatment is for childhood mental issues. It also showed that in 2006 over 13 million children were treated for asthma at a cost of $8 billion.
The other a study that finds more Americans than ever are taking some sort of prescription for mental illness – 73% more than in 1996.
What’s interesting, apart from the fact that we seem to be overmedicating as a society, is that the numbers of patients and the costs of treatments spell hundreds of billions in profits for healthcare and drug makers.
Taking a look at the eleven largest, we find that their market caps total almost $900 billion. That’s a trillion dollars in market value within a handful of companies.
Merck and Co. (NYSE: MRK), Schering-Plough (NYSE: SGP), GlaxoSmithKline ADR (NYSE: GSK), Bristol Myers Squibb (NYSE: BMY) Sanofi-Aventis ADR (NYSE: SNY), AstraZeneca ADR (NYSE: AZN), Johnson & Johnson (NYSE: JNJ), Roche Holding Ltd ADR (OTC: RHHBY) Novartis AG ADR (NYSE: NVS), Eli Lilly & Co (NYSE: LLY) and Wyeth (NYSE: WYE) represent a powerhouse of pharmaceuticals and drug development.
And while we’ve talked before about the potential for mega-mergers, looking at the size of the playing field one discovers that for the most part, these companies are relatively the same size.
The question is whether by merging, and growing larger they will be able to cut redundant overhead for these transactions to make sense. Is there a market cap size where these firms are able to run most effectively, most efficiently, and most profitably?
Companies mentioned in this article: MRK, SGP, GSK, BMY, SNY, AZN, JNJ, RHHBY, LLY and WYE
Any investment contains risk. Please see our disclaimer.
One Response to “Drug Companies: A Powerhouse of Profits”
Comments
By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.
Check out our selection of daily investment research:
 |
 |
Dear all
Would you please describe the efficacy of Bio printing in pharmaceutical. On the other word, there is example of using this method in drug industry and is obtained success.
in addition, there are any solution for ethical problems by using this method instead animal study.
Thanks a lot if guide me.
Reply